Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 0IC7.L
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Weak
33%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 2.35 1.22 1.19
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 2.22 22.36 21.87
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 3.64 31.86 30.74
Cash 34.04 3.28 2.45
Capex 25.67 -1.56 -2.09
Free Cash Flow -34.38 1.46 2.23
Revenue 0.49 45.12 44.90
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 2.28 0.28 0.27
Operating Margin -6.32 0.06 0.06
ROA -1.61 0.01 0.01
ROE -12.82 0.05 0.06
ROIC -11.16 0.03 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 0IC7.L is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 0IC7.L is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 0IC7.L is permitted for members.